Stock Price
1.29
Daily Change
-0.11 -7.86%
Monthly
-23.67%
Yearly
1.57%
Q2 Forecast
1.26

Geron reported $4.04M in Interest Income for its fiscal quarter ending in December of 2025.





Interest Income Change Date
Bio Techne USD 897K 74K Dec/2025
Cassava Sciences USD 1.17M 47K Sep/2025
Cytokinetics USD 11.02M 448K Mar/2026
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Exelixis USD 16.13M 1.3M Mar/2026
Genmab DKK 25M 8M Jun/2025
Geron USD 4.04M 219K Dec/2025
Gilead Sciences USD 95M 7M Dec/2025
Incyte USD 33.69M 2.93M Mar/2026
MacroGenics USD 1.53M 114K Sep/2025
Novavax USD 303K 27K Dec/2021